0001493152-24-002527.txt : 20240116
0001493152-24-002527.hdr.sgml : 20240116
20240116190555
ACCESSION NUMBER: 0001493152-24-002527
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240112
FILED AS OF DATE: 20240116
DATE AS OF CHANGE: 20240116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KUMAR AMIT
CENTRAL INDEX KEY: 0001191905
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37492
FILM NUMBER: 24536415
MAIL ADDRESS:
STREET 1: C/O ACACIA RESEARCH CORPORATION
STREET 2: 500 NEWPORT CENTER DRIVE, 7TH FLOOR
CITY: NEWPORT BEACH
STATE: CA
ZIP: 92660
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anixa Biosciences Inc
CENTRAL INDEX KEY: 0000715446
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 112622630
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1031
BUSINESS ADDRESS:
STREET 1: 3150 ALMADEN EXPRESSWAY, SUITE 250
CITY: SAN JOSE
STATE: CA
ZIP: 95118
BUSINESS PHONE: 408-708-9808
MAIL ADDRESS:
STREET 1: 3150 ALMADEN EXPRESSWAY, SUITE 250
CITY: SAN JOSE
STATE: CA
ZIP: 95118
FORMER COMPANY:
FORMER CONFORMED NAME: ITUS Corp
DATE OF NAME CHANGE: 20140902
FORMER COMPANY:
FORMER CONFORMED NAME: COPYTELE INC
DATE OF NAME CHANGE: 19920703
4
1
ownership.xml
X0508
4
2024-01-12
0
0000715446
Anixa Biosciences Inc
ANIX
0001191905
KUMAR AMIT
C/O ANIXA BIOSCIENCES, INC.
3150 ALMADEN EXPRESSWAY, SUITE 250
SAN JOSE,
CA
95118
1
1
0
0
Chief Executive Officer
0
Employee Stock Option (Right to Buy)
4.39
2024-01-12
4
A
0
700000
0
A
2034-01-12
Common Stock
700000
700000
D
Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan.
The options vest and become exercisable in thirty-six (36) equal monthly installments beginning January 31, 2024.
/s/ Amit Kumar
2024-01-16